Find the latest Core Scientific, Inc. (CORZ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Oct. 19, 2025 — A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more ...